A Multimorbidity-Based, Risk-Stratified Reanalysis of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Trial
Tóm tắt
Từ khóa
Tài liệu tham khảo
Weiss CO, Varadhan R, Puhan MA, Vickers A, Bandeen-Roche K, Boyd CM, Kent DM. Multimorbidity and evidence generation. J Gen Intern Med. 2014;29:653–60.
Ward BW, Schiller JS. Prevalence of multiple chronic conditions among US adults: estimates from the National Health Interview Survey, 2010. Prev Chronic Dis. 2013;10:E65.
He Z, Bian J, Carretta HJ, Lee J, Hogan WR, Shenkman E, Charness N. Prevalence of multiple chronic conditions among older adults in florida and the united states: comparative analysis of the oneflorida data trust and national inpatient sample. J Med Internet Res. 2018;20:e137.
Brilleman SL, Salisbury C. Comparing measures of multimorbidity to predict outcomes in primary care: a cross sectional study. Fam Pract. 2013;30:172–8.
Huntley AL, Johnson R, Purdy S, Valderas JM, Salisbury C. Measures of multimorbidity and morbidity burden for use in primary care and community settings: a systematic review and guide. Ann Fam Med. 2012;10:134–41.
Oudejans I, Mosterd A, Zuithoff NP, Hoes AW. Comorbidity drives mortality in newly diagnosed heart failure: a study among geriatric outpatients. J Card Fail. 2012;18:47–52.
Tamaki S, Yamada T, Morita T, Furukawa Y, Iwasaki Y, Kawasaki M, Kikuchi A, Kawai T, Seo M, Ikeda I, Fukuhara E, Abe M, Nakamura J, Kayama K, Tanabe K, Kawahira M, Fukunami M. Prognostic value of charlson comorbidity index in patients admitted for acute decompensated heart failure with reduced or preserved left ventricular ejection fraction: a prospective study. J Am Coll Cardiol. 2018;71:A829.
Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD, Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825–33.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.
Richardson K, Ananou A, Lafortune L, Brayne C, Matthews FE. Variation over time in the association between polypharmacy and mortality in the older population. Drugs Aging. 2011;28:547–60.
Gage BF, Walraven CV, Pearce L, Hart RG, Koudstaal PJ, Boode BSP, Petersen P. Selecting patients with atrial fibrillation for anticoagulation. Circulation. 2004;110:2287–92.
Konrat C, Boutron I, Trinquart L, Auleley G-R, Ricordeau P, Ravaud P. Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs. PloS One. 2012;7:e33559.
Noheria A, Shrader P, Piccini JP, Fonarow GC, Kowey PR, Mahaffey KW, Naccarelli G, Noseworthy PA, Reiffel JA, Steinberg BA, Thomas LE, Peterson ED, Gersh BJ. Rhythm control versus rate control and clinical outcomes in patients with atrial fibrillation: results from the ORBIT-AF Registry. JACC Clin Electrophysiol. 2016;2:221–9.